Compounds > clopidogrel

clopidogrel and Diabetes Mellitus, Adult-Onset

clopidogrel has been researched along with Diabetes Mellitus, Adult-Onset in 103 studies

Research

Studies (103)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's31 (30.10)29.6817
2010's62 (60.19)24.3611
2020's10 (9.71)2.80

Authors

AuthorsStudies
Li, Q; Wang, J; Ye, Y; Zeng, Y; Zhao, X1
Martínez-Quintana, E; Medina-Gil, JM; Rodríguez-González, F; Saavedra-Santana, P; Santana-Mateos, M; Tugores, A1
Chen, S; Han, Y; Jiang, Z; Li, J; Li, Y; Ma, S; Na, K; Qi, Z; Qiu, M1
Chyrchel, B; Kruszelnicka, O; Surdacki, A1
Grobbee, DE; Heerspink, HJL; Koomen, JV; Lincoff, AM; Nicholls, SJ; Schrieks, IC; Schwartz, GG; Stevens, J; Svensson, A; Wedel, H; Weichert, A1
Ceriello, A; Di Sciascio, G; Grigioni, F; Manfrini, S; Melfi, R; Nicolucci, A; Nusca, A; Pozzilli, P; Proscia, C; Tuccinardi, D; Ussia, GP1
Ajjan, RA; Barwari, T; Grant, PJ; Mayr, M; Parker, WAE; Pearson, SM; Phoenix, F; Schulte, C; Storey, RF1
Alexopoulos, D; Andreadou, I; Dimitriadis, G; Ikonomidis, I; Katogiannis, K; Katsimaglis, G; Kousathana, F; Kyriakou, E; Lambadiari, V; Maratou, E; Papadopoulou, A; Parissis, J; Plotas, P; Stamatelopoulos, K; Taichert, M; Tsantes, AE; Tsoumani, M; Varlamos, C1
Cao, SP; Zheng, P; Zhong, HL; Zhou, MC1
Chen, X; Gu, J; Guo, Y; Shan, Y; Sun, D; Wang, Y; Yao, H1
Fujii, K; Hazama, Y; Kosugi, M; Miyoshi, Y; Nagata, S; Obata, Y; Takayama, K; Uehara, Y; Yamaguchi, H; Yasuda, T1
Aldazabal, A; Cerrato, E; Echavarría-Pinto, M; Escaned, J; Fernández-Ortiz, A; Gonzalo, N; Jimenez-Quevedo, P; Macaya, C; Mejia-Renteria, H; Nombela-Franco, L; Núñez-Gil, IJ; Quirós, A; Rumoroso, JR; Ryan, N; Salinas, P1
Kochubiei, O; Ovrakh, T; Serik, S1
Elisaf, M; Manios, E; Milionis, H; Ntaios, G; Papavasileiou, V; Spengos, K; Vemmos, K1
Baber, U; Badimon, JJ; Contreras, J; Escolar, G; Fuster, V; Linares-Koloffon, CA; Mehran, R; Rey-Mendoza, J; Sartori, S; Smith, DA; Zafar, MU1
Green, JB; Guimarães, PO; Holman, RR; Lokhnygina, Y; Lopes, RD; McGuire, DK; Peterson, ED; Stevens, SR1
Bai, R; Gu, J; Guo, Y; Ren, T; Wang, Y; Yao, H1
Chelstowski, K; Clark, JS; Jastrzebska, M; Lisman, D; Oledzki, S; Siennicka, A; Szelepajlo, A1
Alexopoulos, D; Davlouros, P; Mavronasiou, E; Siapika, A; Stavrou, K; Tsoni, E; Xanthopoulou, I1
Dod, H; Erickson, SW; Marsh, JD; Reddy, HK; Sharma, R; Sharma, RK; Voelker, DJ1
Członkowski, A; Filipiak, KJ; Kapłon-Cieślicka, A; Opolski, G; Postuła, M; Rosiak, M; Trzepla, E1
Ha, SJ; Hwang, SJ; Kim, KS; Kim, MK; Kim, SJ; Kim, W; Kim, WS; Woo, JS1
Fatima, N; Muralidhar, N; Pingali, U1
Li, G; Li, ZQ; Yang, JD; Yang, QY1
Czlonkowski, A; Filipiak, KJ; Janicki, PK; Kaplon-Cieslicka, A; Kondracka, A; Opolski, G; Postula, M; Rosiak, M; Trzepla, E1
Duraj, L; Fedor, M; Fedorová, J; Galajda, P; Kovář, F; Kubisz, P; Mokáň, M; Samoš, M; Šimonová, R; Staško, J1
Badimon, JJ; Balasubramaniam, K; Marshall, SM; Viswanathan, GN; Zaman, AG1
Guo, WY; He, Y; Li, Y; Liu, T; Si, R; Song, LQ; Wang, HC; Yin, T; Yu, J; Zhang, YM1
Byrne, RA; Kastrati, A; Laugwitz, KL; Ndrepepa, G; Neumann, FJ; Pache, J; Pöhler, A; Richardt, G; Schulz, S1
Price, MJ1
Angiolillo, DJ; Bass, TA; Darlington, A; Desai, B; Ferreiro, JL; Franchi, F; Guzman, LA; Jakubowski, JA; Moser, BA; Rollini, F; Sugidachi, A; Tello-Montoliu, A; Ueno, M1
Abergel, H; Ajzenberg, N; Ducrocq, G; Esposito-Farèse, M; Feldman, L; Himbert, D; Huisse, MG; Juliard, JM; Kerner, A; Roussel, R; Sorbets, E; Steg, PG; Triantafyllou, K; Tubach, F1
Cabarkapa, V; Kovacevic, N; Mijovic, R; Mitic, G; Stosic, Z; Zarkov, M1
Bobbert, P; Rauch, U; Schuette, C; Schultheiss, HP; Steffens, D; Stellbaum, C; Witkowski, M1
Ilyas, S; Saboor, M1
Chen, CY; Chiang, YT; Hsieh, CF; Huang, WF1
Bundhun, PK; Chen, MH; Qin, T1
Acosta Martínez, J; Cubero Gómez, JM; Díaz De La Llera, LS; Fernández-Quero, M; Guisado Rasco, A; Mendias Benítez, C; Sánchez González, Á; Villa Gil-Ortega, M1
Bolek, T; Fedor, M; Galajda, P; Kovář, F; Kubisz, P; Mokáň, M; Samoš, M1
Cai, W; Han, Y; Liu, D; Liu, T; Yan, C; Zhang, D; Zhang, X1
Angiolillo, DJ; Carreras, ET; Frelinger, AL; Hochholzer, W; Mega, JL; Michelson, AD; Nordio, F; O'Donoghue, ML; Sabatine, MS; Wiviott, SD1
Bolek, T; Fedor, M; Fedorová, J; Galajda, P; Kovář, F; Kubisz, P; Mokáň, M; Samoš, M; Stančiaková, L; Staško, J1
Barbato, E; Colaiori, I; Di Sciascio, G; Lauria Pantano, A; Mangiacapra, F; Panaioli, E; Pozzilli, P; Ricottini, E1
Alobaidi, Z; Angiolillo, DJ; Bass, TA; Bhatti, M; Cho, JR; DeGroat, C; Engwenyu, LR; Ferrante, E; Franchi, F; Jakubowski, JA; Rollini, F; Sugidachi, A; Zenni, M1
Filipiak, KJ; Janicki, PK; Kaplon-Cieslicka, A; Milanowski, L; Mirowska-Guzel, D; Opolski, G; Ozieranski, K; Peller, M; Pordzik, J; Postula, M; Rosiak, M; Tyminska, A1
Fan, Y; Hong, LF; Li, JJ; Lu, ZH; Luo, SH; Wu, Q; Yan, XN; Yang, B; Ye, F1
Angiolillo, DJ; Aslam, M; Bass, TA; Box, LC; Capranzano, P; Charlton, RK; Desai, B; Goto, S; Guzman, LA; Shoemaker, SB; Suzuki, Y; Zenni, MM1
Aygul, N; Duzenli, MA; Ozdemir, K; Soylu, A; Tokac, M1
Angiolillo, DJ; Antman, EM; Braunwald, E; Corbalan, R; Dalby, AJ; Goodman, SG; McCabe, CH; Meisel, S; Murphy, SA; Purdy, DA; Verheugt, FW; Wiviott, SD1
Angiolillo, DJ; Bass, TA; Capranzano, P; Charlton, R; Desai, B; Guzman, LA; Shoemaker, SB; Zenni, MM1
Bilkova, D; Kala, P; Marinov, I; Motovska, Z; Petr, R; Simek, S; Widimsky, P1
Korenstein, D; McGinn, T; Stulman, J1
Angiolillo, DJ; Brugaletta, S; Campos, B; Cola, C; Martín Yuste, V; Sabaté, M1
Eberli, FR; Roffi, M1
Antonino, MJ; Bliden, KP; Gurbel, PA; Singla, A; Tantry, US1
Kremneva, LV; Shalaev, SV1
Abraham, NG; Ferraris, A; Kruger, AL; McClung, JA; Tsenovoy, P; Vanella, L; Weiss, MB1
Aichele, S; Bigalke, B; Fateh-Moghadam, S; Gawaz, M; Geisler, T; Htun, P; May, AE; Mueller, K; Ninci, E; Stellos, K1
Angiolillo, DJ; Cornel, JH; Erlinge, D; Husted, S; James, S; Kontny, F; Maya, J; Nicolau, JC; Spinar, J; Stevens, SR; Storey, RF; Wallentin, L1
De Boer, A; Deneer, VH; Hackeng, CM; Harmsze, AM; Klungel, OH; Moral, F; Ten Berg, JN; Van Werkum, JW1
Rao, GH1
Barbato, E; Mangiacapra, F; Peace, AJ; Wijns, W1
Alissa, R; Angiolillo, DJ; Bass, TA; Capodanno, D; Capranzano, P; Charlton, RK; Desai, B; Dharmashankar, K; Ferreiro, JL; Kodali, M; Seecheran, N; Tello-Montoliu, A; Tomasello, SD; Ueno, M1
Bal dit Sollier, C; Drouet, L; Henry, P1
Angiolillo, DJ; Badimon, JJ; Baker, BA; Effron, MB; Frelinger, AL; Jakubowski, JA; Michelson, AD; Ojeh, CK; Saucedo, JF; Zhu, B1
Cavuşoğlu, Y; Ozduman, H; Ulus, T1
Crimizade, U; El Adraa, E; El Ghannudi, S; Gachet, C; Jesel, L; Morel, O; Ohlmann, P; Radulescu, B; Wiesel, ML1
Cho, YK; Hong, GR; Hur, SH; Jang, JS; Kim, DI; Kim, DK; Kim, DS; Kim, KB; Kim, U; Kim, YJ; Nam, CW; Park, JS; Seol, SH; Shin, DG; Yang, TH1
Angiolillo, DJ; Capodanno, D; Capranzano, P; Desai, B; Ferreiro, JL; Ueno, M1
Angiolillo, DJ; Bass, TA; Capodanno, D; Charlton, RK; Desai, B; Dharmashankar, K; Ferreiro, JL; Kodali, M; Seecheran, N; Tello-Montoliu, A; Tomasello, SD; Ueno, M1
Banerjee, S; Hall, HM; McGuire, DK1
Érlikh, AD; Gratsianskiĭ, NA1
Alfons, MA; Bedeer, I; Darwish, YW; Hassan, AR; Ismail, EA; Nasr, HA; Saad, AA1
Angiolillo, DJ; Bass, TA; Capodanno, D; Capranzano, P; Charlton, RK; Desai, B; Dharmashankar, K; Ferreiro, JL; Kodali, M; Tello-Montoliu, A; Tomasello, SD; Ueno, M1
Azcona, L; Jiménez Mateos-Cáceres, P; López Farré, AJ; Macaya, C; Modrego, J; Rodríguez, P; Segura, A; Zamorano-León, JJ1
Lacasa, RC; Linares Vicente, JA; Pérez, JO1
Angiolillo, DJ; Ferreiro, JL1
Angiolillo, DJ; Bass, TA; Box, LC; Desai, B; Ferreiro, JL; Guzman, LA; Rollini, F; Suryadevara, S; Tello-Montoliu, A; Ueno, M; Zenni, M1
Bliden, KP; Gurbel, PA; Hwang, JY; Hwang, SJ; Jeong, YH; Kim, S; Koh, EH; Kwak, CH; Kwon, TJ; Park, JR; Park, Y; Tantry, US1
Badimon, JJ; Balasubramaniam, K; Marshall, SM; Schechter, CB; Viswanathan, GN; Zaman, AG1
Bal dit Sollier, C; Dillinger, JG; Drissa, A; Drouet, L; Henry, P; Logeart, D; Manzo Silberman, S; Sideris, G; Voicu, S1
Valentine, N; Van de Laar, FA; van Driel, ML1
Feijge, MA; Giesen, PL; Heemskerk, JW; Huijberts, M; van der Meijden, PE; van Raak, LP1
Agil, C; Akay, F; Akay, H; Bahceci, M; Tuzcu, A1
Alfonso, F; Angiolillo, DJ; Bañuelos, C; Bass, TA; Bernardo, E; Costa, MA; Escaned, J; Fernandez-Ortiz, A; Hernández, R; Jimenez-Quevedo, P; Macaya, C; Moreno, R; Ramírez, C; Sabaté, M2
Chen, WH; Kaul, U; Lam, KF; Lau, CP; Lau, YK; Lee, MK; Lee, PY; Leung, AW; Leung, SK; Li, SK; Ng, W; Tan, HC; Tse, HF1
Bhatt, DL; Brogan, GX; Farkouh, ME; Gibler, WB; Mulgund, J; Ohman, EM; Peterson, ED; Pollack, CV; Roe, MT1
Berge, C; Deme, M; Gershlick, AH; Guagliumi, G; Guyon, P; Lotan, C; Schofer, J; Seth, A; Sousa, JE; Stoll, HP; Urban, P; Wijns, W1
Herrmann, HC; Julien, MB; Makkar, K; Spinler, SA; Wilensky, RL1
Heliopoulos, I; Maltezos, E; Papanas, N; Piperidou, H1
Din, JN; Fox, KA; Harding, SA; Maciocia, PM; Newby, DE; Sarma, J1
Angiolillo, DJ1
Legrand, D; Scheen, AJ1
Ang, CK; Chin, SP; Fong, YY; Gudum, HR; Liew, CK; Liew, HB; Ong, TK; Rapaee, A; Sim, KH; Tay, SP1
Angiolillo, DJ; Bass, TA; Bernardo, E; Charlton, RK; Costa, MA; Desai, B; Guzman, LA; Shoemaker, SB; Yuan, H; Zenni, MM1
Alfonso, F; Angiolillo, DJ; Bañuelos, C; Bass, TA; Bernardo, E; Costa, MA; Escaned, J; Fernandez-Ortiz, A; Guzman, LA; Hernández-Antolin, R; Jimenez-Quevedo, P; Macaya, C; Moreno, R; Palazuelos, J; Sabaté, M1
Schmaier, AH; Simon, DI1
Barsness, G; Hanley, DF; Malinin, AI; Pokov, A; Serebruany, VL1
Dupliakov, DV1
Angiolillo, DJ; Bass, TA; Bernardo, E; Charlton, RK; Costa, MA; Desai, B; Guzman, LA; Shoemaker, SB; Suzuki, Y; Zenni, MM1
Hackeng, CM; Kelder, JC; Postma, S; ten Berg, JM; Topcu, Y; van Werkum, JW; Verheugt, FW1
Hanley, DF; Malinin, AI; Pokov, AN; Serebruany, VL1

Reviews

10 review(s) available for clopidogrel and Diabetes Mellitus, Adult-Onset

ArticleYear
Comparing the effectiveness and safety between triple antiplatelet therapy and dual antiplatelet therapy in type 2 diabetes mellitus patients after coronary stents implantation: a systematic review and meta-analysis of randomized controlled trials.
    BMC cardiovascular disorders, 2015, Oct-09, Volume: 15

    Topics: Acute Coronary Syndrome; Aspirin; Cilostazol; Clopidogrel; Coronary Artery Disease; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Stents; Tetrazoles; Thrombosis; Ticlopidine

2015
Type 2 Diabetes and ADP Receptor Blocker Therapy.
    Journal of diabetes research, 2016, Volume: 2016

    Topics: Adenosine; Adenosine Monophosphate; Blood Platelets; Cardiovascular Diseases; Clopidogrel; Diabetes Mellitus, Type 2; Drug Resistance; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Risk Factors; Ticagrelor; Ticlopidine; Treatment Outcome

2016
Diabetes mellitus: a prothrombotic state implications for outcomes after coronary revascularization.
    Vascular health and risk management, 2009, Volume: 5, Issue:1

    Topics: Angioplasty, Balloon, Coronary; Aspirin; Cardiovascular Agents; Clopidogrel; Coronary Angiography; Coronary Stenosis; Coronary Thrombosis; Diabetes Mellitus, Type 2; Drug-Eluting Stents; Female; Humans; Medication Adherence; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Risk Factors; Sirolimus; Ticlopidine; Treatment Outcome

2009
Diabetes and acute coronary syndromes.
    Best practice & research. Clinical endocrinology & metabolism, 2009, Volume: 23, Issue:3

    Topics: Acute Coronary Syndrome; Anticoagulants; Aspirin; Blood Glucose; Clopidogrel; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Enoxaparin; Hirudins; Humans; Hypoglycemic Agents; Peptide Fragments; Piperazines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prasugrel Hydrochloride; Randomized Controlled Trials as Topic; Recombinant Proteins; Thiophenes; Thrombosis; Ticlopidine

2009
[Acute coronary syndrome in patients with carbohydrate metabolic disturbances (a review)].
    Terapevticheskii arkhiv, 2009, Volume: 81, Issue:10

    Topics: Acute Coronary Syndrome; Blood Glucose; Cardiovascular Diseases; Clinical Trials as Topic; Clopidogrel; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperglycemia; Hypoglycemic Agents; Insulin Resistance; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine

2009
Management of type-2 diabetes with anti-platelet therapies: special reference to aspirin.
    Frontiers in bioscience (Scholar edition), 2011, 01-01, Volume: 3, Issue:1

    Topics: Arachidonic Acid; Aspirin; Blood Platelets; Clopidogrel; Diabetes Mellitus, Type 2; Drug Resistance; Humans; Platelet Aggregation Inhibitors; Thienopyridines; Ticlopidine; Vascular Diseases

2011
Variability of clopidogrel response in patients with type 2 diabetes mellitus.
    Diabetes & vascular disease research, 2011, Volume: 8, Issue:4

    Topics: Clopidogrel; Coronary Artery Disease; Diabetes Complications; Diabetes Mellitus, Type 2; Drug Monitoring; Drug Resistance; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Purinergic P2Y Receptor Antagonists; Ticlopidine; Treatment Outcome

2011
Challenges and perspectives of antiplatelet therapy in patients with diabetes mellitus and coronary artery disease.
    Current pharmaceutical design, 2012, Volume: 18, Issue:33

    Topics: Aspirin; Blood Glucose; Blood Platelets; Clopidogrel; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Humans; Insulin; Insulin Resistance; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Ticlopidine; Treatment Outcome

2012
Adenosine-diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitus.
    The Cochrane database of systematic reviews, 2012, Nov-14, Volume: 11

    Topics: Aspirin; Cardiovascular Diseases; Clopidogrel; Diabetes Mellitus, Type 2; Dipyridamole; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Ticlopidine

2012
[Clopidogrel and statins or once more on the danger of direct transfer of results of experimental studies in clinical practice].
    Kardiologiia, 2008, Volume: 48, Issue:2

    Topics: Atorvastatin; Clopidogrel; Coronary Thrombosis; Diabetes Mellitus, Type 2; Heptanoic Acids; Humans; Hypercholesterolemia; Platelet Aggregation Inhibitors; Pyrroles; Ticlopidine

2008

Trials

35 trial(s) available for clopidogrel and Diabetes Mellitus, Adult-Onset

ArticleYear
Exposure and response analysis of aleglitazar on cardiovascular risk markers and safety outcomes: An analysis of the AleCardio trial.
    Diabetes, obesity & metabolism, 2020, Volume: 22, Issue:1

    Topics: Aged; Cardiovascular Diseases; Clopidogrel; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Interactions; Female; Heart Disease Risk Factors; Humans; Male; Middle Aged; Oxazoles; PPAR alpha; PPAR gamma; Risk Factors; Thiophenes

2020
Aspirin, clopidogrel and prasugrel monotherapy in patients with type 2 diabetes mellitus: a double-blind randomised controlled trial of the effects on thrombotic markers and microRNA levels.
    Cardiovascular diabetology, 2020, 01-07, Volume: 19, Issue:1

    Topics: Aged; Aspirin; Biomarkers; Blood Coagulation; Clopidogrel; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Fibrin; Humans; Male; MicroRNAs; Middle Aged; P-Selectin; Platelet Aggregation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Primary Prevention; Secondary Prevention; Thrombosis; Time Factors; Treatment Outcome

2020
β-Amyloid and mitochondrial-derived peptide-c are additive predictors of adverse outcome to high-on-treatment platelet reactivity in type 2 diabetics with revascularized coronary artery disease.
    Journal of thrombosis and thrombolysis, 2020, Volume: 49, Issue:3

    Topics: Aged; Amyloid beta-Peptides; Blood Platelets; Clopidogrel; Coronary Artery Disease; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Humans; Male; Malondialdehyde; Middle Aged; Mitochondrial Proteins; Myocardial Revascularization; Platelet Activation; Risk Factors

2020
PRotective Effect on the coronary microcirculation of patients with DIabetes by Clopidogrel or Ticagrelor (PREDICT): study rationale and design. A randomized multicenter clinical trial using intracoronary multimodal physiology.
    Cardiovascular diabetology, 2017, 05-19, Volume: 16, Issue:1

    Topics: Adenosine; Blood Platelets; Clinical Protocols; Clopidogrel; Coronary Artery Disease; Coronary Circulation; Diabetes Mellitus, Type 2; Humans; Microcirculation; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prospective Studies; Purinergic P2Y Receptor Antagonists; Research Design; Risk Factors; Spain; Ticagrelor; Ticlopidine; Time Factors; Treatment Outcome; Vasodilation

2017
[IMPACT OF ATORVASTATIN AND ROSUVASTATIN ON RESIDUAL ON-CLOPIDOGREL TREATMENT PLATELET REACTIVITY IN PATIENTS WITH ISCHEMIC HEART DISEASE AND TYPE 2 DIABETES MELLITUS AFTER ACUTE CORONARY SYNDROME].
    Georgian medical news, 2017, Issue:265

    Topics: Acute Coronary Syndrome; Aspirin; Atorvastatin; Blood Platelets; Clopidogrel; Diabetes Mellitus, Type 2; Drug Interactions; Drug Substitution; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Ischemia; Platelet Aggregation Inhibitors; Rosuvastatin Calcium; Ticlopidine

2017
Antithrombotic potency of ticagrelor versus clopidogrel in type-2 diabetic patients with cardiovascular disease.
    Thrombosis and haemostasis, 2017, 10-05, Volume: 117, Issue:10

    Topics: Adenosine; Aged; Blood Platelets; Cardiovascular Diseases; Clopidogrel; Coronary Thrombosis; Cross-Over Studies; Diabetes Mellitus, Type 2; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Function Tests; Ticagrelor; Ticlopidine; Time Factors; Treatment Outcome

2017
Antithrombotic treatment gap among patients with atrial fibrillation and type 2 diabetes.
    International journal of cardiology, 2019, 08-15, Volume: 289

    Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypoglycemic Agents; Male; Middle Aged; Platelet Aggregation Inhibitors; Sitagliptin Phosphate; Stroke; Time Factors; Treatment Outcome; Vitamin K

2019
Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with diabetes.
    Diabetes care, 2013, Volume: 36, Issue:8

    Topics: Acute Coronary Syndrome; Adenosine; Aged; Clopidogrel; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Piperazines; Platelet Activation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Single-Blind Method; Thiophenes; Ticagrelor; Ticlopidine

2013
The effect of doubling the dose of acetylsalicylic acid (ASA) on platelet function parameters in patients with type 2 diabetes and platelet hyperreactivity during treatment with 75 mg of ASA: a subanalysis of the AVOCADO study.
    Kardiologia polska, 2013, Volume: 71, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Aspirin; Blood Platelets; Clopidogrel; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Platelet Function Tests; Prospective Studies; Ticlopidine

2013
Effect of cilostazol addition or clopidogrel doubling on platelet function profiles in diabetic patients undergoing a percutaneous coronary intervention.
    Coronary artery disease, 2013, Volume: 24, Issue:8

    Topics: Blood Platelets; Cilostazol; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Cross-Over Studies; Diabetes Mellitus, Type 2; Drug Resistance; Drug Therapy, Combination; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Republic of Korea; Tetrazoles; Ticlopidine; Time Factors; Treatment Outcome

2013
Study of pharmacodynamic interaction of Phyllanthus emblica extract with clopidogrel and ecosprin in patients with type II diabetes mellitus.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2014, Apr-15, Volume: 21, Issue:5

    Topics: Aged; Aspirin; Clopidogrel; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Herb-Drug Interactions; Humans; Male; Middle Aged; Phyllanthus emblica; Phytotherapy; Plant Extracts; Platelet Aggregation Inhibitors; Prospective Studies; Ticlopidine

2014
Effect of ASA dose doubling versus switching to clopidogrel on plasma inflammatory markers concentration in patients with type 2 diabetes and high platelet reactivity: the AVOCADO study.
    Cardiology journal, 2013, Volume: 20, Issue:5

    Topics: Aspirin; Biomarkers; Blood Platelets; C-Reactive Protein; CD40 Ligand; Chi-Square Distribution; Clopidogrel; Diabetes Mellitus, Type 2; Drug Substitution; Humans; Inflammation Mediators; Interleukin-6; Logistic Models; Multivariate Analysis; Odds Ratio; Platelet Aggregation Inhibitors; Platelet Function Tests; Poland; Prospective Studies; Ticlopidine; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha

2013
Reticulated platelets and antiplatelet therapy response in diabetic patients.
    Journal of thrombosis and thrombolysis, 2015, Volume: 40, Issue:2

    Topics: Adult; Aged; Blood Platelets; Clopidogrel; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Ticlopidine

2015
VERifyNow in DIabetes high-on-treatment platelet reactivity: a pharmacodynamic study on switching from clopidogrel to prasugrel.
    Acta cardiologica, 2015, Volume: 70, Issue:6

    Topics: Acute Coronary Syndrome; Aged; Blood Platelets; Clopidogrel; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Function Tests; Prasugrel Hydrochloride; Prospective Studies; Single-Blind Method; Ticlopidine; Treatment Outcome

2015
Association between insulin receptor substrate-1 polymorphisms and high platelet reactivity with clopidogrel therapy in coronary artery disease patients with type 2 diabetes mellitus.
    Cardiovascular diabetology, 2016, Mar-22, Volume: 15

    Topics: Aged; Aspirin; Blood Platelets; Clopidogrel; Coronary Artery Disease; Diabetes Mellitus, Type 2; Drug Resistance; Drug Therapy, Combination; Female; Flow Cytometry; Gene Frequency; Haplotypes; Humans; Insulin Receptor Substrate Proteins; Male; Middle Aged; P-Selectin; Percutaneous Coronary Intervention; Pharmacogenetics; Phenotype; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Polymorphism, Single Nucleotide; Ticlopidine; Time Factors; Treatment Outcome

2016
Diabetes mellitus, CYP2C19 genotype, and response to escalating doses of clopidogrel. Insights from the ELEVATE-TIMI 56 Trial.
    Thrombosis and haemostasis, 2016, 07-04, Volume: 116, Issue:1

    Topics: Aged; Clopidogrel; Coronary Artery Disease; Cytochrome P-450 CYP2C19; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Genotype; Humans; Male; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Ticlopidine

2016
Clopidogrel Versus Ticagrelor for Antiplatelet Maintenance in Diabetic Patients Treated With Percutaneous Coronary Intervention: Results of the CLOTILDIA Study (Clopidogrel High Dose Versus Ticagrelor for Antiplatelet Maintenance in Diabetic Patients).
    Circulation, 2016, Sep-13, Volume: 134, Issue:11

    Topics: Adenosine; Clopidogrel; Coronary Artery Disease; Diabetes Complications; Diabetes Mellitus, Type 2; Female; Humans; Male; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Ticagrelor; Ticlopidine

2016
New single-nucleotide polymorphisms associated with differences in platelet reactivity and their influence on survival in patients with type 2 diabetes treated with acetylsalicylic acid: an observational study.
    Acta diabetologica, 2017, Volume: 54, Issue:4

    Topics: Aged; Alleles; Aspirin; Blood Platelets; Clopidogrel; Diabetes Mellitus, Type 2; Female; Genotype; Humans; Inflammation; Male; Middle Aged; Platelet Activation; Polymorphism, Single Nucleotide; Receptors, Thromboxane A2, Prostaglandin H2; Survival Analysis; Ticlopidine

2017
A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 study.
    European heart journal, 2008, Volume: 29, Issue:18

    Topics: Adult; Aged; Aged, 80 and over; Aspirin; Cilostazol; Clopidogrel; Coronary Artery Disease; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Female; Humans; Male; Middle Aged; Pilot Projects; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Tetrazoles; Ticlopidine; Treatment Outcome

2008
Comparison of increased aspirin dose versus combined aspirin plus clopidogrel therapy in patients with diabetes mellitus and coronary heart disease and impaired antiplatelet response to low-dose aspirin.
    The American journal of cardiology, 2008, Aug-15, Volume: 102, Issue:4

    Topics: Aspirin; Blood Platelets; Clopidogrel; Coronary Artery Disease; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Failure

2008
Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial I
    Circulation, 2008, Oct-14, Volume: 118, Issue:16

    Topics: Administration, Oral; Aged; Clopidogrel; Coronary Thrombosis; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Insulin; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Thiophenes; Thrombolytic Therapy; Ticlopidine; Treatment Outcome

2008
Factors influencing clopidogrel efficacy in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention: statin's advantage and the smoking "paradox".
    Journal of cardiovascular pharmacology, 2009, Volume: 53, Issue:5

    Topics: Age Factors; Aged; Angioplasty, Balloon, Coronary; Aspirin; Body Mass Index; Cell Adhesion Molecules; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Heparin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Male; Microfilament Proteins; Phosphoproteins; Platelet Aggregation Inhibitors; Renal Insufficiency; Sex Factors; Smoking; Ticlopidine; Treatment Outcome

2009
Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial.
    European heart journal, 2010, Volume: 31, Issue:24

    Topics: Acute Coronary Syndrome; Adenosine; Aged; Blood Glucose; Clopidogrel; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glycated Hemoglobin; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Ticagrelor; Ticlopidine; Treatment Outcome

2010
Sulfonylureas and on-clopidogrel platelet reactivity in type 2 diabetes mellitus patients.
    Platelets, 2011, Volume: 22, Issue:2

    Topics: Aged; Blood Platelets; Clopidogrel; Cohort Studies; Cytochrome P-450 Enzyme System; Diabetes Mellitus, Type 2; Drug Interactions; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Function Tests; Sulfonylurea Compounds; Ticlopidine

2011
A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 Trial.
    European heart journal, 2011, Volume: 32, Issue:7

    Topics: Adolescent; Adult; Aged; Aspirin; Clopidogrel; Coronary Artery Disease; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Platelet Activation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Prospective Studies; Thiophenes; Ticlopidine; Treatment Outcome; Young Adult

2011
Impact of pentoxifylline on platelet function profiles in patients with type 2 diabetes mellitus and coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel.
    JACC. Cardiovascular interventions, 2011, Volume: 4, Issue:8

    Topics: Aged; Aspirin; Blood Platelets; Cell Adhesion Molecules; Clopidogrel; Coronary Artery Disease; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Florida; Humans; Male; Microfilament Proteins; Middle Aged; Pentoxifylline; Phosphodiesterase Inhibitors; Phosphoproteins; Phosphorylation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Receptors, Purinergic P2Y12; Ticlopidine; Time Factors; Treatment Outcome

2011
Impact of clopidogrel and aspirin treatment on the expression of proteins in platelets from type-2 diabetic patients with stable coronary ischemia.
    Journal of pharmaceutical sciences, 2012, Volume: 101, Issue:8

    Topics: Aged; Amino Acid Sequence; Aspirin; Blood Platelets; Clopidogrel; Coronary Disease; Cytoskeletal Proteins; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Gene Expression Regulation; Humans; Male; Molecular Sequence Data; Platelet Aggregation Inhibitors; Platelet Factor 4; Proteome; Ticlopidine

2012
Effects of pioglitazone on platelet P2Y12-mediated signalling in clopidogrel-treated patients with type 2 diabetes mellitus.
    Thrombosis and haemostasis, 2012, Volume: 108, Issue:5

    Topics: Aged; Aspirin; Clopidogrel; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Interactions; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Pioglitazone; Platelet Aggregation; Prospective Studies; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Signal Transduction; Thiazolidinediones; Ticlopidine

2012
Thrombus and antiplatelet therapy in type 2 diabetes mellitus. A prospective study after non-ST elevation acute coronary syndrome and a randomised, blinded, placebo-controlled study in stable angina.
    Thrombosis and haemostasis, 2012, Volume: 108, Issue:5

    Topics: Acute Coronary Syndrome; Aged; Angina, Stable; Aspirin; Clopidogrel; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Thrombosis; Ticlopidine

2012
Biological efficacy of twice daily aspirin in type 2 diabetic patients with coronary artery disease.
    American heart journal, 2012, Volume: 164, Issue:4

    Topics: Analysis of Variance; Arachidonic Acid; Aspirin; Clopidogrel; Coronary Artery Disease; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Administration Schedule; Drug Resistance; Female; Humans; Male; Middle Aged; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Ticlopidine

2012
A randomized, double-blind, placebo-controlled trial of abciximab for prevention of in-stent restenosis in diabetic patients after coronary stenting: results of the ASIAD (Abciximab in Stenting Inhibits restenosis Among Diabetics) Trial.
    The Journal of invasive cardiology, 2005, Volume: 17, Issue:10

    Topics: Abciximab; Antibodies, Monoclonal; Aspirin; Blood Coagulation; Clopidogrel; Coronary Angiography; Coronary Disease; Coronary Restenosis; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Follow-Up Studies; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Stents; Ticlopidine

2005
Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease: results of the Optimizing Antiplatelet Therapy in Diabetes Mellitus (OPTIMUS) study.
    Circulation, 2007, Feb-13, Volume: 115, Issue:6

    Topics: Adenosine Diphosphate; Adult; Aged; Aged, 80 and over; Clopidogrel; Coronary Artery Disease; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Pilot Projects; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Ticlopidine

2007
Effects of clopidogrel and aspirin in combination versus aspirin alone on platelet activation and major receptor expression in diabetic patients: the PLavix Use for Treatment Of Diabetes (PLUTO-Diabetes) trial.
    American heart journal, 2008, Volume: 155, Issue:1

    Topics: Adult; Analysis of Variance; Aspirin; Biomarkers; Blood Chemical Analysis; Clopidogrel; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Therapy, Combination; Female; Flow Cytometry; Humans; Male; Middle Aged; Myocardial Ischemia; Pilot Projects; Platelet Activation; Platelet Aggregation; Platelet Function Tests; Probability; Prognosis; Receptor, PAR-2; Reference Values; Risk Assessment; Survival Rate; Ticlopidine; Treatment Outcome

2008
Functional effects of high clopidogrel maintenance dosing in patients with inadequate platelet inhibition on standard dose treatment.
    The American journal of cardiology, 2008, Feb-15, Volume: 101, Issue:4

    Topics: Aged; Clopidogrel; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y12; Ticlopidine

2008
Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-b
    Clinical therapeutics, 2008, Volume: 30, Issue:2

    Topics: Adult; Aged; Aspirin; Aspirin, Dipyridamole Drug Combination; Biomarkers; Clopidogrel; Diabetes Mellitus, Type 2; Dipyridamole; Drug Combinations; Drug Therapy, Combination; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Pilot Projects; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Single-Blind Method; Ticlopidine; Time Factors; Treatment Outcome

2008

Other Studies

58 other study(ies) available for clopidogrel and Diabetes Mellitus, Adult-Onset

ArticleYear
Impact of Pancreatic β-Cell Function on Clopidogrel Responsiveness and Outcomes in Chinese Nondiabetic Patients Undergoing Elective Percutaneous Coronary Intervention.
    Cardiovascular drugs and therapy, 2023, Volume: 37, Issue:3

    Topics: Clopidogrel; Diabetes Mellitus, Type 2; East Asian People; Humans; Insulin Resistance; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome

2023
Clinical and Pharmacological Parameters Determine Relapse During Clopidogrel Treatment of Acute Coronary Syndrome.
    Journal of clinical pharmacology, 2022, Volume: 62, Issue:6

    Topics: Acute Coronary Syndrome; Aspirin; Calcium Channel Blockers; Clopidogrel; Coronary Artery Disease; Cytochrome P-450 CYP2C19; Diabetes Mellitus, Type 2; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Recurrence; Retrospective Studies; Ticlopidine; Treatment Outcome

2022
Predictors and long-term outcomes of in-hospital switching from clopidogrel to ticagrelor among patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2022, Volume: 99 Suppl 1

    Topics: Acute Coronary Syndrome; Clopidogrel; Diabetes Mellitus, Type 2; Hemorrhage; Hospitals; Humans; Male; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Ticagrelor; Treatment Outcome

2022
Endothelial biomarkers and platelet reactivity on ticagrelor versus clopidogrel in patients after acute coronary syndrome with and without concomitant type 2 diabetes: a preliminary observational study.
    Cardiovascular diabetology, 2022, 11-17, Volume: 21, Issue:1

    Topics: Acute Coronary Syndrome; Aged; Biomarkers; Clopidogrel; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Stroke Volume; Ticagrelor; Ventricular Function, Left

2022
Incremental role of glycaemic variability over HbA1c in identifying type 2 diabetic patients with high platelet reactivity undergoing percutaneous coronary intervention.
    Cardiovascular diabetology, 2019, 11-09, Volume: 18, Issue:1

    Topics: Aged; Biomarkers; Blood Glucose; Blood Platelets; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Risk Assessment; Risk Factors; Treatment Outcome

2019
Subacute stent thrombosis in a patient with type 2 diabetes and clopidogrel resistance: A case report
.
    International journal of clinical pharmacology and therapeutics, 2020, Volume: 58, Issue:8

    Topics: Clopidogrel; Diabetes Mellitus, Type 2; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Thrombosis; Ticlopidine

2020
Type 2 diabetes mellitus decreases systemic exposure of clopidogrel active metabolite through upregulation of P-glycoprotein in rats.
    Biochemical pharmacology, 2020, Volume: 180

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Clopidogrel; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Intestinal Absorption; Male; Microsomes, Liver; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Up-Regulation

2020
Hypoglycemia during the Concomitant Use of Repaglinide and Clopidogrel in an Elderly Patient with Type 2 Diabetes and Severe Renal Insufficiency.
    Internal medicine (Tokyo, Japan), 2021, Volume: 60, Issue:6

    Topics: Aged; Blood Glucose; Carbamates; Clopidogrel; Diabetes Mellitus, Type 2; Humans; Hypoglycemia; Hypoglycemic Agents; Piperidines; Renal Insufficiency

2021
Aspirin Versus Clopidogrel for Type 2 Diabetic Patients with First-Ever Noncardioembolic Acute Ischemic Stroke: Ten-Year Survival Data from the Athens Stroke Outcome Project.
    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2017, Volume: 26, Issue:12

    Topics: Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Chi-Square Distribution; Clopidogrel; Diabetes Mellitus, Type 2; Female; Greece; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Patient Discharge; Platelet Aggregation Inhibitors; Proportional Hazards Models; Protective Factors; Recurrence; Retrospective Studies; Risk Factors; Secondary Prevention; Stroke; Ticlopidine; Time Factors; Treatment Outcome

2017
Enhanced Platelet Response to Clopidogrel in Zucker Diabetic Fatty Rats due to Impaired Clopidogrel Inactivation by Carboxylesterase 1 and Increased Exposure to Active Metabolite.
    Drug metabolism and disposition: the biological fate of chemicals, 2019, Volume: 47, Issue:8

    Topics: Administration, Oral; Animals; Blood Platelets; Carboxylesterase; Clopidogrel; Cytochrome P-450 Enzyme System; Diabetes Mellitus, Type 2; Disease Models, Animal; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Rats, Zucker

2019
Evaluation of platelet reactivity during combined antiplatelet therapy in patients with stable coronary artery disease in relation to diabetes type 2 and the GPIIB/IIIA receptor gene polymorphism.
    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2019, Volume: 70, Issue:2

    Topics: Blood Platelets; Clopidogrel; Coronary Artery Disease; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Integrin beta3; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Polymorphism, Genetic; Prospective Studies; Thromboxane B2

2019
Platelet function testing to predict hyporesponsiveness to clopidogrel in patients with chest pain seen in the emergency department.
    Vascular health and risk management, 2013, Volume: 9

    Topics: Age Factors; Aged; Black or African American; Blood Platelets; Chest Pain; Clopidogrel; Diabetes Mellitus, Type 2; Drug Resistance; Drug Therapy, Combination; Emergency Service, Hospital; Female; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Prospective Studies; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Risk Assessment; Risk Factors; Sex Factors; Stents; Ticlopidine; Treatment Outcome

2013
Acquired pure red cell aplasia due to treatment with clopidogrel: first case report.
    Journal of thrombosis and thrombolysis, 2014, Volume: 38, Issue:2

    Topics: Clopidogrel; Coronary Disease; Diabetes Complications; Diabetes Mellitus, Type 2; Female; Humans; Hyperlipidemias; Hypertension; Middle Aged; Platelet Aggregation Inhibitors; Red-Cell Aplasia, Pure; Ticlopidine

2014
Clopidogrel resistance in diabetic patient with acute myocardial infarction due to stent thrombosis.
    The American journal of emergency medicine, 2014, Volume: 32, Issue:5

    Topics: Aged, 80 and over; Aspirin; Clopidogrel; Coronary Angiography; Diabetes Mellitus, Type 2; Drug Resistance; Electrocardiography; Heparin; Humans; Myocardial Infarction; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Stents; Thiophenes; Thrombosis; Ticlopidine

2014
Differences in thrombus structure and kinetics in patients with type 2 diabetes mellitus after non ST elevation acute coronary syndrome.
    Thrombosis research, 2014, Volume: 133, Issue:5

    Topics: Acute Coronary Syndrome; Aged; Aspirin; Clopidogrel; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Thrombosis; Ticlopidine

2014
CYP2C19 polymorphisms and coronary heart disease risk factors synergistically impact clopidogrel response variety after percutaneous coronary intervention.
    Coronary artery disease, 2014, Volume: 25, Issue:5

    Topics: Aged; Biomarkers; Blood Platelets; Body Mass Index; Cell Adhesion Molecules; China; Clopidogrel; Coronary Disease; Cytochrome P-450 CYP2C19; Diabetes Mellitus, Type 2; Drug Resistance; Female; Gene Frequency; Genotype; Humans; Male; Microfilament Proteins; Middle Aged; Oligonucleotide Array Sequence Analysis; Percutaneous Coronary Intervention; Pharmacogenetics; Phenotype; Phosphoproteins; Platelet Aggregation Inhibitors; Platelet Function Tests; Polymorphism, Genetic; Risk Factors; Ticlopidine; Treatment Outcome

2014
Prognostic value of bleeding after percutaneous coronary intervention in patients with diabetes.
    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2014, Volume: 10, Issue:1

    Topics: Abciximab; Aged; Antibodies, Monoclonal; Anticoagulants; Antithrombins; Aspirin; Clopidogrel; Coronary Artery Disease; Diabetes Mellitus, Type 2; Female; Hemorrhage; Heparin; Hirudins; Humans; Immunoglobulin Fab Fragments; Logistic Models; Male; Middle Aged; Peptide Fragments; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prognosis; Proportional Hazards Models; Recombinant Proteins; Risk Factors; Stents; Ticlopidine

2014
Diabetes mellitus and clopidogrel response variability.
    Journal of the American College of Cardiology, 2014, Sep-09, Volume: 64, Issue:10

    Topics: Clopidogrel; Coronary Artery Disease; Diabetes Mellitus, Type 2; Female; Humans; Male; Platelet Aggregation; Purinergic P2Y Receptor Antagonists; Ticlopidine

2014
Impaired responsiveness to the platelet P2Y12 receptor antagonist clopidogrel in patients with type 2 diabetes and coronary artery disease.
    Journal of the American College of Cardiology, 2014, Sep-09, Volume: 64, Issue:10

    Topics: Adult; Aged; Aspirin; Clopidogrel; Cohort Studies; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Purinergic P2Y Receptor Antagonists; Reference Values; Risk Assessment; Ticlopidine; Treatment Outcome

2014
Impact of diabetes mellitus and metabolic syndrome on acute and chronic on-clopidogrel platelet reactivity in patients with stable coronary artery disease undergoing drug-eluting stent placement.
    American heart journal, 2014, Volume: 168, Issue:6

    Topics: Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Monitoring; Drug-Eluting Stents; Female; France; Humans; Israel; Male; Metabolic Syndrome; Middle Aged; Odds Ratio; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prognosis; Prospective Studies; Ticlopidine

2014
The effect of clopidogrel on platelet activity in patients with and without type-2 diabetes mellitus: a comparative study.
    Cardiovascular diabetology, 2015, Feb-03, Volume: 14

    Topics: Aged; Blood Platelets; Clopidogrel; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome

2015
Effect of Clopidogrel on Platelet CD Markers in Normal Individuals and in Patients with Untreated Type 2 Diabetes Mellitus.
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2015, Volume: 25, Issue:5

    Topics: Adult; Aged; Biomarkers; Blood Platelets; Case-Control Studies; Clopidogrel; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Flow Cytometry; Humans; Male; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Ticlopidine

2015
Effects of Clopidogrel and Proton Pump Inhibitors on Cardiovascular Events in Patients with Type 2 Diabetes Mellitus after Drug-Eluting Stent Implantation: A Nationwide Cohort Study.
    PloS one, 2015, Volume: 10, Issue:8

    Topics: Acute Coronary Syndrome; Aged; Clopidogrel; Coronary Artery Bypass; Diabetes Mellitus, Type 2; Drug-Eluting Stents; Female; Humans; Male; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Retrospective Studies; Risk Factors; Ticlopidine

2015
The Impact of Type 2 Diabetes on the Efficacy of ADP Receptor Blockers in Patients with Acute ST Elevation Myocardial Infarction: A Pilot Prospective Study.
    Journal of diabetes research, 2016, Volume: 2016

    Topics: Adult; Aged; Aged, 80 and over; Aspirin; Case-Control Studies; Clopidogrel; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Flow Cytometry; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Pilot Projects; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prasugrel Hydrochloride; Prospective Studies; Purinergic P2Y Receptor Antagonists; ST Elevation Myocardial Infarction; Ticlopidine

2016
Impact of chronic kidney disease on platelet P2Y
    Thrombosis and haemostasis, 2017, 01-05, Volume: 117, Issue:1

    Topics: Biomarkers; Blood Platelets; Cell Adhesion Molecules; Clopidogrel; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Resistance; Humans; Microfilament Proteins; Phosphoproteins; Platelet Aggregation Inhibitors; Prospective Studies; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Renal Insufficiency, Chronic; Signal Transduction; Ticlopidine

2017
Predictive value of non-fasting remnant cholesterol for short-term outcome of diabetics with new-onset stable coronary artery disease.
    Lipids in health and disease, 2017, Jan-13, Volume: 16, Issue:1

    Topics: Aged; Biomarkers; C-Reactive Protein; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Clopidogrel; Cohort Studies; Coronary Angiography; Coronary Artery Disease; Diabetes Mellitus, Type 2; Female; Fibrinogen; Follow-Up Studies; Glycated Hemoglobin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Neutrophils; Prognosis; Proportional Hazards Models; ROC Curve; Ticlopidine; Treatment Outcome

2017
Impact of P2Y(12) inhibitory effects induced by clopidogrel on platelet procoagulant activity in type 2 diabetes mellitus patients.
    Thrombosis research, 2009, Volume: 124, Issue:3

    Topics: Blood Coagulation Factors; Clopidogrel; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y12; Ticlopidine

2009
Clopidogrel for preventing cardiovascular events.
    The Mount Sinai journal of medicine, New York, 2009, Volume: 76, Issue:2

    Topics: Aspirin; Clopidogrel; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Evidence-Based Medicine; Female; Humans; Hypertension; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Prognosis; Stroke; Ticlopidine

2009
The relation between platelet reactivity and glycemic control in diabetic patients with cardiovascular disease on maintenance aspirin and clopidogrel therapy.
    American heart journal, 2009, Volume: 158, Issue:5

    Topics: Adult; Aged; Aspirin; Blood Glucose; Blood Platelets; Cardiovascular Diseases; Clopidogrel; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome

2009
Usefulness of clopidogrel to protect against diabetes-induced vascular damage.
    The American journal of cardiology, 2010, Apr-01, Volume: 105, Issue:7

    Topics: Adult; Aged; Cell Count; Clopidogrel; Diabetes Complications; Diabetes Mellitus, Type 2; Endothelial Cells; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Ticlopidine; Vascular Diseases

2010
Impact of inflammatory state and metabolic control on responsiveness to dual antiplatelet therapy in type 2 diabetics after PCI: prognostic relevance of residual platelet aggregability in diabetics undergoing coronary interventions.
    Clinical research in cardiology : official journal of the German Cardiac Society, 2010, Volume: 99, Issue:11

    Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Biomarkers; Blood Glucose; C-Reactive Protein; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Cytokines; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunoassay; Inflammation; Male; Pilot Projects; Platelet Aggregation Inhibitors; Retrospective Studies; Ticlopidine; Treatment Outcome

2010
Lack of correlation between platelet reactivity and glycaemic control in type 2 diabetes mellitus patients treated with aspirin and clopidogrel.
    Journal of thrombosis and thrombolysis, 2011, Volume: 32, Issue:1

    Topics: Aged; Aged, 80 and over; Angina Pectoris; Aspirin; Blood Glucose; Blood Platelets; Clopidogrel; Diabetes Complications; Diabetes Mellitus, Type 2; Female; Glycemic Index; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Function Tests; Ticlopidine; Time Factors

2011
Functional profile of the platelet P2Y₁₂ receptor signalling pathway in patients with type 2 diabetes mellitus and coronary artery disease.
    Thrombosis and haemostasis, 2011, Volume: 105, Issue:4

    Topics: Aged; Blood Platelets; Cell Adhesion Molecules; Clopidogrel; Coronary Artery Disease; Diabetes Mellitus, Type 2; Female; Humans; Male; Microfilament Proteins; Middle Aged; Phosphoproteins; Phosphorylation; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Signal Transduction; Thrombosis; Ticlopidine

2011
[Antiplatelet agents and diabetes mellitus].
    Annales de cardiologie et d'angeiologie, 2010, Volume: 59 Suppl 2

    Topics: Aspirin; Cardiovascular Diseases; Clopidogrel; Diabetes Mellitus, Type 2; Humans; Platelet Aggregation Inhibitors; Ticlopidine

2010
A 23-year patency of a saphenous vein graft in a patient with diabetes mellitus.
    Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology, 2011, May-25, Volume: 11, Issue:3

    Topics: Aged; Angina Pectoris; Clopidogrel; Coronary Artery Bypass; Diabetes Mellitus, Type 2; Humans; Male; Platelet Aggregation Inhibitors; Saphenous Vein; Ticlopidine; Time Factors

2011
Impaired inhibition of P2Y(12) by clopidogrel is a major determinant of cardiac death in diabetes mellitus patients treated by percutaneous coronary intervention.
    Atherosclerosis, 2011, Volume: 217, Issue:2

    Topics: Aged; Angioplasty, Balloon, Coronary; Cell Adhesion Molecules; Chi-Square Distribution; Clopidogrel; Coronary Artery Disease; Diabetes Mellitus, Type 2; Drug Resistance; Female; Flow Cytometry; France; Heart Diseases; Humans; Kaplan-Meier Estimate; Male; Microfilament Proteins; Middle Aged; Myocardial Infarction; Phosphoproteins; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Proportional Hazards Models; Prospective Studies; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Registries; Risk Assessment; Risk Factors; Thrombosis; Ticlopidine; Time Factors; Treatment Outcome

2011
Detection of clopidogrel hyporesponsiveness using a point-of-care assay and the impact of additional cilostazol administration after coronary stent implantation in diabetic patients.
    The Korean journal of internal medicine, 2011, Volume: 26, Issue:2

    Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Chi-Square Distribution; Cilostazol; Clopidogrel; Coronary Disease; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Logistic Models; Male; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Point-of-Care Systems; Predictive Value of Tests; Purinergic P2Y Receptor Antagonists; Registries; Republic of Korea; Risk Assessment; Risk Factors; Stents; Tetrazoles; Ticlopidine; Treatment Outcome

2011
Impact of adjunctive cilostazol therapy versus high maintenance dose of clopidogrel in suboptimal responders with diabetes mellitus.
    Revista espanola de cardiologia (English ed.), 2012, Volume: 65, Issue:1

    Topics: Aspirin; Blood Coagulation; Blood Platelets; Cilostazol; Clopidogrel; Diabetes Mellitus, Type 2; Humans; Platelet Aggregation Inhibitors; Platelet Function Tests; Randomized Controlled Trials as Topic; Receptors, Purinergic P2Y12; Tetrazoles; Thrombosis; Ticlopidine

2012
[Acute coronary syndromes in hospitalized patients with diabetes. Data from the RECORD registry].
    Kardiologiia, 2011, Volume: 51, Issue:11

    Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Clinical Protocols; Clopidogrel; Coronary Angiography; Diabetes Mellitus, Type 2; Electrocardiography; Female; Hospital Mortality; Humans; Male; Outcome and Process Assessment, Health Care; Platelet Aggregation Inhibitors; Prospective Studies; Registries; Risk Factors; Ticlopidine

2011
Platelet function profile post-clopidogrel therapy in patients with type 2 diabetes undergoing coronary stent implantation.
    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2012, Volume: 18, Issue:3

    Topics: Aged; Clopidogrel; Coronary Vessels; Diabetes Complications; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Stents; Ticlopidine

2012
Cigarette smoking is associated with a dose-response effect in clopidogrel-treated patients with diabetes mellitus and coronary artery disease: results of a pharmacodynamic study.
    JACC. Cardiovascular interventions, 2012, Volume: 5, Issue:3

    Topics: Aged; Aspirin; Biomarkers; Blood Platelets; Cell Adhesion Molecules; Clopidogrel; Coronary Artery Disease; Cotinine; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Florida; Humans; Male; Microfilament Proteins; Middle Aged; Odds Ratio; Phosphoproteins; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Smoking; Ticlopidine; Time Factors; Treatment Outcome

2012
Long-term successful percutaneous coronary intervention in factor VII deficiency.
    The Journal of invasive cardiology, 2012, Volume: 24, Issue:6

    Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Stenosis; Diabetes Mellitus, Type 2; Factor VII Deficiency; Follow-Up Studies; Humans; Male; Middle Aged; Obesity, Morbid; Platelet Aggregation Inhibitors; Radiography; Risk Assessment; Stents; Thromboembolism; Ticlopidine; Time Factors; Treatment Outcome

2012
Pharmacodynamic effect of cilostazol plus standard clopidogrel versus double-dose clopidogrel in patients with type 2 diabetes undergoing percutaneous coronary intervention.
    Diabetes care, 2012, Volume: 35, Issue:11

    Topics: Cilostazol; Clopidogrel; Diabetes Mellitus, Type 2; Female; Humans; Male; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Tetrazoles; Ticlopidine

2012
Platelet P2Y12 receptors enhance signalling towards procoagulant activity and thrombin generation. A study with healthy subjects and patients at thrombotic risk.
    Thrombosis and haemostasis, 2005, Volume: 93, Issue:6

    Topics: Adenosine Diphosphate; Adult; Aged; Blood Platelets; Calcium Signaling; Case-Control Studies; Clopidogrel; Diabetes Mellitus, Type 2; Humans; In Vitro Techniques; Membrane Proteins; Middle Aged; Phosphatidylserines; Platelet Aggregation Inhibitors; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Stroke; Thrombin; Thrombosis; Ticlopidine

2005
Serious clopidogrel associated renal hematoma in a type 2 diabetic patient with primary hyperparathyroidism after extracorporeal shock wave lithotripsy.
    Saudi medical journal, 2005, Volume: 26, Issue:6

    Topics: Clopidogrel; Diabetes Mellitus, Type 2; Hematoma; Humans; Hyperparathyroidism, Primary; Kidney Calculi; Kidney Diseases; Lithotripsy; Male; Middle Aged; Nephrectomy; Platelet Aggregation Inhibitors; Ticlopidine

2005
Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment.
    Diabetes, 2005, Volume: 54, Issue:8

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Platelets; Clopidogrel; Coronary Disease; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; P-Selectin; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Ticlopidine

2005
Treatment disparities in the care of patients with and without diabetes presenting with non-ST-segment elevation acute coronary syndromes.
    Diabetes care, 2006, Volume: 29, Issue:1

    Topics: Acute Disease; Adrenergic beta-Antagonists; Adult; Aspirin; Cardiac Catheterization; Clopidogrel; Coronary Artery Bypass; Coronary Disease; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Heparin; Humans; Male; Platelet Aggregation Inhibitors; Recurrence; Survival Analysis; Ticlopidine

2006
Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry.
    Circulation, 2006, Mar-21, Volume: 113, Issue:11

    Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Cause of Death; Clopidogrel; Comorbidity; Coronary Disease; Coronary Restenosis; Coronary Stenosis; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drug Implants; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Internet; Male; Middle Aged; Myocardial Infarction; Product Surveillance, Postmarketing; Registries; Risk Factors; Sirolimus; Stents; Thrombosis; Ticlopidine; United States

2006
Rash with both clopidogrel and ticlopidine in two patients following percutaneous coronary intervention with drug-eluting stents.
    The Annals of pharmacotherapy, 2006, Volume: 40, Issue:6

    Topics: Angioplasty, Balloon, Coronary; Cardiomyopathy, Dilated; Clopidogrel; Coronary Artery Bypass; Coronary Restenosis; Diabetes Mellitus, Type 2; Drug Eruptions; Humans; Male; Middle Aged; Myocardial Ischemia; Platelet Aggregation Inhibitors; Poliomyelitis; Stents; Ticlopidine

2006
Simultaneous, painless, homolateral oculomotor and trochlear nerve palsies in a patient with type 2 diabetes mellitus. Neuropathy or brainstem infarction?
    Acta diabetologica, 2006, Volume: 43, Issue:1

    Topics: Aged; Cerebral Infarction; Clopidogrel; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Neuropathies; Diagnosis, Differential; Female; Humans; Hyperlipidemias; Hypertension; Insulin; Magnetic Resonance Imaging; Paralysis; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome

2006
Insulin therapy is associated with platelet dysfunction in patients with type 2 diabetes mellitus on dual oral antiplatelet treatment.
    Journal of the American College of Cardiology, 2006, Jul-18, Volume: 48, Issue:2

    Topics: Aged; Aspirin; Clopidogrel; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Multivariate Analysis; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Ticlopidine

2006
Clopidogrel reduces platelet-leucocyte aggregation, monocyte activation and RANTES secretion in type 2 diabetes mellitus.
    Heart (British Cardiac Society), 2006, Volume: 92, Issue:9

    Topics: Chemokine CCL5; Clopidogrel; Diabetes Mellitus, Type 2; Humans; Leukocytes, Mononuclear; Lymphocyte Activation; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Ticlopidine

2006
Tackling the diabetic platelet: is high clopidogrel dosing the answer?
    Journal of thrombosis and haemostasis : JTH, 2006, Volume: 4, Issue:12

    Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Disease; Diabetes Mellitus, Type 2; Humans; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Thrombosis; Ticlopidine

2006
Aspirin and clopidogrel resistance in patients with diabetes mellitus.
    European heart journal, 2006, Volume: 27, Issue:23

    Topics: Aspirin; Clopidogrel; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Resistance; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Ticlopidine

2006
Platelet non-responsiveness to dual antiplatelet therapy and relation to coronary disease among diabetes patients.
    International journal of cardiology, 2007, Jun-12, Volume: 118, Issue:3

    Topics: Adult; Aspirin; Blood Platelets; Case-Control Studies; Clopidogrel; Coronary Disease; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pilot Projects; Reference Values; Risk Assessment; Ticlopidine; Treatment Failure

2007
Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease.
    Journal of the American College of Cardiology, 2007, Oct-16, Volume: 50, Issue:16

    Topics: Aged; Angina, Unstable; Aspirin; Blood Platelets; Clopidogrel; Coronary Artery Disease; Death, Sudden, Cardiac; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Humans; Male; Multivariate Analysis; Myocardial Infarction; Outcome Assessment, Health Care; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Predictive Value of Tests; Prognosis; Prospective Studies; Renal Insufficiency; ROC Curve; Sensitivity and Specificity; Stroke; Ticlopidine

2007
Sweet and sticky: diabetic platelets, enhanced reactivity, and cardiovascular risk.
    Journal of the American College of Cardiology, 2007, Oct-16, Volume: 50, Issue:16

    Topics: Angina, Unstable; Aspirin; Blood Platelets; Clopidogrel; Coronary Artery Disease; Death, Sudden, Cardiac; Diabetes Mellitus, Type 2; Humans; Myocardial Infarction; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Prognosis; Stroke; Ticlopidine

2007
Effects of diabetes mellitus on platelet reactivity after dual antiplatelet therapy with aspirin and clopidogrel.
    Thrombosis and haemostasis, 2008, Volume: 99, Issue:3

    Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Cohort Studies; Coronary Artery Disease; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Thrombosis; Ticlopidine; Treatment Outcome

2008